Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $800,509 - $895,900
-4,117 Reduced 58.21%
2,956 $579,000
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $65,584 - $75,059
357 Added 5.32%
7,073 $1.49 Million
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $1.29 Million - $1.75 Million
6,716 New
6,716 $1.36 Million
Q1 2019

May 13, 2019

SELL
$104.82 - $146.73 $269,072 - $376,655
-2,567 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$105.09 - $137.23 $27,533 - $35,954
-262 Reduced 9.26%
2,567 $291,000
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $317,159 - $380,613
2,829 New
2,829 $381,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.